VRTX - バ―テックス・ファ―マシュ―ティカルズ （Vertex Pharmaceuticals Incorporated）VRTXのニュース
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors 2023/02/02 22:30:00 MarketWatch
Shares of Vertex Pharmaceuticals Inc. slid 4.25% to $303.78 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the…
Top 5 4th Quarter Trades of FOSTER DYKEMA CABOT & CO INC/MA 2023/02/01 20:00:08 GuruFocus
Related Stocks: IEFA , SHW , LLY , VRTX , XLV ,
MOODY LYNN & LIEBERSON, LLC Buys 4, Sells 1 in 4th Quarter 2023/02/01 20:00:07 GuruFocus
Related Stocks: GOOGL , 48D , UBER , VRTX , NEE ,
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today 2023/01/31 21:04:32 Benzinga
Vertex Pharmaceuticals (NASDAQ: VRTX ) has outperformed the market over the past 15 years by 12.93% on an annualized basis producing an average annual return of 20.63%. Currently, Vertex Pharmaceuticals has a market capitalization of $82.90 billion. Buying $100 In VRTX: If … Full story available on Benzinga.com
This Clue Helps Spot The Best Stocks To Watch, Including These 11 2023/01/31 20:16:07 Investor''s Business Daily
The best stocks to watch often hail from the top-ranked industries. Here''s a look 11 stocks, including VRTX ad ULTA, that fit that bill.
Vertex to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 9 2023/01/04 13:00:00 Business Wire
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 11:15 a.m. ET/8:15 a.m. PT. A live webcast of management''s remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company''s website. About Vertex Vertex is a globa
Cashing out in biotech in 2022: On-target predictions for AbbVie, Vertex and Genmab 2023/01/01 19:00:00 Seeking Alpha
Seeking Alpha contributors accurately predicted the 2022 bull run of AbbVie (ABBV), Vertex Pharma (VRTX), and Genmab (GMAB), sometimes even against the consensus. Read the full story here.
5 Stocks That Outperformed the S&P 500 in 2022 2022/12/30 20:06:22 GuruFocus
Stocks that outperformed as market finishes one of the worst years since 2008 Check out Vanguard Health Care Fund Stock Picks » Download GuruFolio Report of Vanguard Health Care Fund (Updated on 12/29/2022) , Check out Jim Simons Stock Picks » Download GuruFolio Report of Jim Simons (Updated on 12/29/2022) Related Stocks: VRTX , APD , FISV , MPC , VMW ,
Vertex: Progress Towards Expanding Cystic Fibrosis Market Continues 2022/12/28 12:55:47 Seeking Alpha
Vertex Pharmaceuticals is doing very well with respect to sales of its CF franchise. Click here to read why VRTX is a great speculative biotech play.
Is Vertex Pharmaceuticals a Buy? 2022/12/27 11:15:00 The Motley Fool
There''s more growth ahead for this biotech giant.
Cashing out in biotech in 2022: On-target predictions for AbbVie, Vertex and Genmab 2023/01/01 19:00:00 Seeking Alpha
Seeking Alpha contributors accurately predicted the 2022 bull run of AbbVie (ABBV), Vertex Pharma (VRTX), and Genmab (GMAB), sometimes even against the consensus. Read the full story here.
5 Stocks That Outperformed the S&P 500 in 2022 2022/12/30 20:06:22 GuruFocus
Stocks that outperformed as market finishes one of the worst years since 2008 Check out Vanguard Health Care Fund Stock Picks » Download GuruFolio Report of Vanguard Health Care Fund (Updated on 12/29/2022) , Check out Jim Simons Stock Picks » Download GuruFolio Report of Jim Simons (Updated on 12/29/2022) Related Stocks: VRTX , APD , FISV , MPC , VMW ,
Vertex: Progress Towards Expanding Cystic Fibrosis Market Continues 2022/12/28 12:55:47 Seeking Alpha
Vertex Pharmaceuticals is doing very well with respect to sales of its CF franchise. Click here to read why VRTX is a great speculative biotech play.